Nureca (NURECA) | Stock Overview & Key Data
Nureca Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: ₹2,315.00 on October 4, 2021
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Join Our India Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Financial Highlights
Quarter Income Flow
Jun 30, 2025
Annual Income Flow
2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Nureca
NURECA
|
2.67B Small-cap | 2.79% | -13.68% | -4.29% | -16.61% | -24.18% | -17.00% | -36.56% | -85.03% | -65.77% | -65.77% | -65.77% |
|
HSIL Limited
HSIL
|
53.70B Mid-cap | 7.81% | 9.94% | 19.48% | -10.96% | -14.17% | -22.20% | 6.42% | 200.14% | 806.19% | 1,225.70% | 2,328.54% |
|
Fischer Medical
FISCHER
|
24.43B Small-cap | 10.75% | 2.12% | 7.06% | -21.38% | -14.16% | -57.40% | -70.45% | 1,348.00% | -12.14% | 101.56% | 439.49% |
|
Universus Photo
UNIVPHOTO
|
4.55B Small-cap | -1.10% | -18.10% | -25.22% | 52.86% | 66.19% | 44.40% | -6.88% | 46.95% | 496.84% | 496.84% | 496.84% |
|
Choksi Imaging
CHOKSI
|
959.50M Small-cap | 5.36% | 4.02% | 0.31% | 11.98% | 30.83% | 33.30% | 197.28% | 387.48% | 445.49% | 296.93% | 956.51% |
|
Maestros Electronics
METSL
|
759.31M Small-cap | 2.75% | 2.60% | -2.81% | 11.41% | 3.48% | -1.74% | 121.89% | 106.33% | 277.01% | 262.22% | 262.22% |
Ownership & Short Interest
Calculate Your Nureca Investment Returns
Long-Term Investment Performance Analysis
Nureca stock price in Feb 2021 was ₹678.00, A ₹1,000.00 lump sum investment in Nureca made 5 years ago would be worth approximately ₹347.57 today, representing a negative return of -65.24%. This translates to an annualized return (CAGR) of -18.05%.
5 Years 3 Months Investment Scenario (Feb 2021 - Jun 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is NURECA's 52-week high and low?
- In the last 52 weeks, Nureca reached a high of ₹343.00 (on October 20, 2025) and a low of ₹204.00 (on March 30, 2026).
- What is the market cap and P/E ratio for NURECA?
- Curious about Nureca's size and valuation? Its market capitalization stands at 2.67B. When it comes to valuation, the P/E ratio (trailing twelve months) is 24.00, and the forward P/E (looking ahead) is N/A.
- Does NURECA pay dividends? If so, what's the yield?
- As for dividends, Nureca isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Nureca's main competitors or similar companies to consider before investing?
When looking at Nureca, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return HSIL Limited
HSIL53.70B Healthcare Medical Devices -22.20% 6.42% Fischer Medical
FISCHER24.43B Healthcare Medical Devices -57.40% -70.45% Universus Photo
UNIVPHOTO4.55B Healthcare Medical Devices 44.40% -6.88% Choksi Imaging
CHOKSI959.50M Healthcare Medical Devices 33.30% 197.28% Maestros Electronics
METSL759.31M Healthcare Medical Devices -1.74% 121.89% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Nureca Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Nureca's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 0.44%, the Debt to Equity ratio from the most recent quarter is 2.71, and its Gross Profit Margin stands at 36.32%.
- What is the recent revenue and earnings growth for NURECA?
- Looking at Nureca's growth, its revenue over the trailing twelve months (TTM) was INR1B. Compared to the same quarter last year (YoY), quarterly revenue grew by 49.80%, and quarterly earnings saw a YoY growth of 27.10%.
- How much of NURECA stock is held by insiders and institutions?
- Wondering who owns Nureca stock? Company insiders (like executives and directors) hold about 68.13% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 0.00%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.